|
|
|
Welcome to the APA Website!
Connect with your Wholesaler | | Mirixa Corporation recently launched the Community CCRxSM Formulary Review Program on the MirixaProSM platform. Designed to promote formulary alignment, this service provides pharmacies with the opportunity to receive a $30 reimbursement per formulary review service. | | | URGENT UPDATED INFORMATION
Some Health Net LIS Members Being Charged Incorrect Copayment Amounts
| 2009 Health Care Reform |
| | Tamiflu Suspension
Tamiflu Suspension is now on backorder from the manufacture until the end of November. With the increase in cases of Swine Flu, there will no doubt be an increase in the demand for Tamiflu suspension. The wholesalers are now out and what is still available in local pharmacies will soon be gone. This is a Roche and FDA approved formulation for compounding the suspension from the capsules. The capsules are still available through the wholesalers | Arkansas State Cache Antiviral
Medications
The Arkansas Department of Health is developing a network to distribute Arkansas State Cache Antiviral Medications. The purpose of this network is to ensure access to antiviral medications for the citizens of Arkansas. more >>> |
Medicaid Prescriptions | Biotech Drugs |
| | Upcoming CE |
The Arkansas Pharmacists Association (APA) was founded in 1882 as the professional association for the profession of pharmacy in Arkansas. The Association represents over 2,000 members consisting of pharmacists, pharmacy students and members of the industry who support the objectives of the Association. Members are kept abreast of pertinent healthcare issues and trends through the quarterly journal, newsletters and the APA web page. APA also provides its members with opportunities for professional growth through continuing education programs, District Meetings and an Annual State Convention. Legislative advocacy at both the state and federal levels are another important focus of APA. Overall, the Arkansas Pharmacists Association strives to enhance the practice of pharmacy and to improve public health through rational cost-effective drug therapy and outcomes-oriented drug therapy management.
|
|
|
